FDA
approval
· 2019-05-28
FDA Approved: RANOLAZINE — Original Application (Actavis Pharma, Inc.)
Summary
The FDA approved Actavis Pharma, Inc.'s original ANDA for ranolazine, a generic oral therapy for chronic angina. This approval makes a generic version of ranola…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RANOLAZINE (RANOLAZINE)